INVA

Innoviva, Inc. Common Stock

19.10

USD

-0.14

-0.73%

Nov 06, 15:59 UTC -5

Closed

After-Market

19.11

0.00

+0.03%

Innoviva, Inc. Common Stock (INVA) Earnings

INVA Earnings Reports

Positive Surprise Ratio

INVA beat 17 of 41 last estimates.

41%

Next Report

Next Week

Date of Next Report

Nov 11, 2026

Estimate for Q3 26 (Revenue/ EPS)

$117.61M

$0.52

Implied change from Q2 26 (Revenue/ EPS)

-1.66%

-146.02%

Implied change from Q3 25 (Revenue/ EPS)

+9.10%

-51.85%

Innoviva, Inc. Common Stock earnings per share and revenue

On Aug 05, 2026, INVA reported earnings of -1.13 USD per share (EPS) for Q2 26, missing the estimate of 0.44 USD, resulting in a -356.35% surprise. Revenue reached 119.59 million, compared to an expected 113.20 million, with a 5.64% difference. The market reacted with a +2.93% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 5 analysts forecast an EPS of 0.52 USD, with revenue projected to reach 117.61 million USD, implying an decrease of -146.02% EPS, and decrease of -1.66% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Eli Lilly & Co.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$6.32

Actual

$7.48

Surprise

+18.32%

ABBVIE INC.

Report Date

Oct 30, 2026 For Q3 26

Estimate

$3.82

Actual

$3.82

Surprise

-0.08%

Merck & Co., Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$2.10

Actual

$2.49

Surprise

+18.46%

Novartis AG

Report Date

Oct 27, 2026 For Q3 26

Estimate

$2.33

Actual

$2.46

Surprise

+5.50%

Novo-Nordisk A/S

Report Date

Nov 04, 2026 For Q3 26

Estimate

$4.85

Actual

$5.91

Surprise

+21.86%

Pfizer Inc.

Report Date

Nov 03, 2026 For Q3 26

Estimate

$0.73

Actual

$0.87

Surprise

+18.76%

Sanofi - ADR

Report Date

Oct 30, 2026 For Q3 26

Estimate

$2.80

Actual

$1.82

Surprise

-35.08%

FAQ

What were Innoviva, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Innoviva, Inc. Common Stock reported EPS of -$1.13, missing estimates by -356.35%, and revenue of $119.59M, 5.64% above expectations.

How did the market react to Innoviva, Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 2.93%, changed from $20.51 before the earnings release to $21.11 the day after.

When is Innoviva, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 11, 2026.

What are the forecasts for Innoviva, Inc. Common Stock's next earnings report?

Based on 5 analysts, Innoviva, Inc. Common Stock is expected to report EPS of $0.52 and revenue of $117.61M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.